Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study

Brendan O'Kelly,Louise Vidal,Tina McHugh,James Woo,Gordana Avramovic,John S Lambert

Brain, Behavior, & Immunity - Health（2022）

Cited 21|Views10
No score
Abstract
•Low dose naltrexone (LDN) is safe to use in patients with long covid (LC).•In patients with LC for a median 11 months, LDN reduced symptoms at 2 months.•In this cohort, LDN also improved well-being in 6 of 7 parameters at 2 months.
More
Translated text
Key words
SARS-CoV-2,COVID-19,Post COVID-19 syndrome,SF-12,Long covid
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined